Sonoma Pharmaceuticals Inc (SNOA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 3,579 | 3,391 | 3,439 | 3,138 | 2,731 |
| Cost of Goods | 2,218 | 2,085 | 2,348 | 1,678 | 1,741 |
| Gross Profit | 1,361 | 1,306 | 1,091 | 1,460 | 990 |
| Operating Expenses | 2,429 | 2,564 | 2,848 | 2,982 | 2,939 |
| Operating Income | -850 | -1,173 | -1,409 | -844 | -1,208 |
| Other Income | 387 | 176 | 50 | -79 | -90 |
| Pre-tax Income | -463 | -997 | -1,359 | -923 | -1,298 |
| Income Tax | 147 | 146 | -292 | -57 | 186 |
| Net Income Continuous | -610 | -1,143 | -1,067 | -866 | -1,484 |
| Net Income | $-610 | $-1,143 | $-1,067 | $-866 | $-1,484 |
| EPS Basic Total Ops | -0.59 | -1.34 | 2.51 | -1.59 | -5.75 |
| EPS Basic Continuous Ops | -0.59 | -1.34 | 2.46 | -1.59 | -5.75 |
| EPS Diluted Total Ops | -0.59 | -1.34 | 2.51 | -1.59 | -5.75 |
| EPS Diluted Continuous Ops | -0.59 | -1.34 | 2.46 | -1.59 | -5.75 |
| EPS Diluted Before Non-Recurring Items | -0.59 | -1.40 | -1.40 | N/A | N/A |
| EBITDA(a) | $-815 | $-1,134 | $-1,368 | $-799 | $-1,163 |